Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · IEX Real-Time Price · USD
-0.19 (-1.45%)
At close: Apr 16, 2024, 4:00 PM
-1.43 (-11.11%)
Pre-market: Apr 17, 2024, 4:49 AM EDT

Precision BioSciences Revenue

In the year 2023, Precision BioSciences had annual revenue of $48.73M with 94.15% growth. Revenue in the quarter ending December 31, 2023 was $7.04M, a -33.59% decrease year-over-year.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
89.01M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 324.24M
PetMed Express 276.97M
Aurora Cannabis 200.73M
SHL Telemedicine 57.10M
Aclaris Therapeutics 31.25M
Elutia 24.75M
Celularity 14.79M
BioXcel Therapeutics 1.38M
Revenue Rankings